Evidence map›Paper›PMID 42696264›Full record

ArticlePhotochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology2026

ADSCs-Exo ameliorates UVB-induced skin DNA damage via p62-RNF168-dependent histone ubiquitination.

Wei Gao, Chen Ai, Peijun Song, Siqi Li, Xueting Han, Minting Lv, Fei Gao, Fangzhou Huang, Weijing Chen, Zhenzhu Li and 3 more

Abstract read
PubMed Publisher
In one paragraph

Article in Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Wei Gao *Department of Pharmacy, Anhui Engineering Technology Research Center of Biochemical Pharmaceutical, Bengbu Medical University, 2600 Donghai Avenue, Bengbu, 233030, China.
Chen Ai *Department of Pharmacy, Anhui Engineering Technology Research Center of Biochemical Pharmaceutical, Bengbu Medical University, 2600 Donghai Avenue, Bengbu, 233030, China.
Peijun SongDepartment of Plastic Surgery and Burn, The First Affiliated Hospital of Bengbu Medical University, Bengbu, 233000, Anhui, China.
Siqi LiDepartment of Pharmacy, Anhui Engineering Technology Research Center of Biochemical Pharmaceutical, Bengbu Medical University, 2600 Donghai Avenue, Bengbu, 233030, China.
Xueting HanDepartment of Pharmacy, Anhui Engineering Technology Research Center of Biochemical Pharmaceutical, Bengbu Medical University, 2600 Donghai Avenue, Bengbu, 233030, China.
Minting LvDepartment of Pharmacy, Anhui Engineering Technology Research Center of Biochemical Pharmaceutical, Bengbu Medical University, 2600 Donghai Avenue, Bengbu, 233030, China.
Fei GaoDepartment of Pharmacy, Anhui Engineering Technology Research Center of Biochemical Pharmaceutical, Bengbu Medical University, 2600 Donghai Avenue, Bengbu, 233030, China.
Fangzhou HuangDepartment of Pharmacy, Anhui Engineering Technology Research Center of Biochemical Pharmaceutical, Bengbu Medical University, 2600 Donghai Avenue, Bengbu, 233030, China.
Weijing ChenDepartment of Pharmacy, Anhui Engineering Technology Research Center of Biochemical Pharmaceutical, Bengbu Medical University, 2600 Donghai Avenue, Bengbu, 233030, China.
Zhenzhu LiDepartment of Pharmacy, Anhui Engineering Technology Research Center of Biochemical Pharmaceutical, Bengbu Medical University, 2600 Donghai Avenue, Bengbu, 233030, China.
Huiyan ZhangDepartment of Pharmacy, Anhui Engineering Technology Research Center of Biochemical Pharmaceutical, Bengbu Medical University, 2600 Donghai Avenue, Bengbu, 233030, China.
Qingqing LiDepartment of Pharmacy, Anhui Engineering Technology Research Center of Biochemical Pharmaceutical, Bengbu Medical University, 2600 Donghai Avenue, Bengbu, 233030, China.
Yu-Shuai WangDepartment of Pharmacy, Anhui Engineering Technology Research Center of Biochemical Pharmaceutical, Bengbu Medical University, 2600 Donghai Avenue, Bengbu, 233030, China. wangyushuai666@sina.com.ORCID http://orcid.org/0000-0001-7071-9465

Funding

the Graduate Research Innovation Program of Bengbu Medical University Byycx24062the Key Projects of Outstanding Young Talents Support Program in Universities of Anhui Province YQYB2024040the Key Projects of Outstanding Young Talents Support Program in Universities of Anhui Province YQZD2023061the Longhu Talent Project of Bengbu Medical University LH250102001the National Natural Science Foundation of China 82103755the Natural Science Research Project of Anhui Educational Committee 2024AH030042the Natural Science Research Project of Anhui Educational Committee 2024AH051242
6 · The paper itself

Abstract

Mesenchymal stem cell-secreted paracrine factors, especially exosome, has emerged as promising therapeutic candidates for mitigating UVB-induced cutaneous photodamage. While adipose-derived stem cell exosome (ADSCs-Exo) are well documented to alleviate UVB-triggered DNA damage, the precise molecular mechanisms underlying this effect remain poorly elucidated. Herein, we illustrated that ADSCs-Exo drastically curbed UVB-elicited cellular apoptosis, cell cycle arrest, comet tail formation, γH2AX foci accumulation, and cyclobutane pyrimidine dimer deposition in HaCaT keratinocytes. Consistent with the in vitro findings, ADSCs-Exo substantially mitigated cutaneous DNA damage and skin cell apoptosis in UVB-exposed Kunming mice. Notably, pharmacological autophagy blockade using 3-methyladenine effectively abolished these ADSCs-Exo-dependent protective outcomes. Mechanistically, ADSCs-Exo treatment facilitated the degradation of core autophagy receptors, including p62, NBR1, and TAX1BP1. Subsequent functional validation assays identified ectopic p62 overexpression as the sole manipulation capable of counteracting ADSCs-Exo's cytoprotective potency. Co-immunoprecipitation assays further verified a direct interaction between p62 and the E3 ubiquitin ligase RNF168. P62 overexpression hindered RNF168 recruitment to DNA lesion sites, accompanied by suppressed histone K63-linked polyubiquitination and H2AX ubiquitination, as well as impaired recruitment of the DNA damage repair factors BRCA1 and RAD51. Furthermore, genetic knockdown of RNF168 markedly diminished histone H2AX ubiquitination and compromised the protective functions of ADSCs-Exo. Collectively, this study uncovered a novel autophagy-dependent p62-RNF168 regulatory axis governing ADSCs-Exo-mediated photoprotection, providing a promising therapeutic strategy for ultraviolet-associated skin DNA damage and photocarcinogenesis.

Indexed as

ADSCs-ExoHistone ubiquitinationp62RNF168UVB

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.